Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and Definitive Healthcare (NASDAQ:DH – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.
Volatility & Risk
Firefly Neuroscience has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Firefly Neuroscience and Definitive Healthcare, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| Definitive Healthcare | 3 | 6 | 0 | 1 | 1.90 |
Insider and Institutional Ownership
5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 6.9% of Firefly Neuroscience shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Firefly Neuroscience and Definitive Healthcare”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $1.14 million | 17.20 | -$19.88 million | ($0.59) | -2.12 |
| Definitive Healthcare | $232.70 million | 0.45 | -$138.93 million | ($1.60) | -0.62 |
Firefly Neuroscience has higher earnings, but lower revenue than Definitive Healthcare. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Firefly Neuroscience and Definitive Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -506.23% | -90.17% | -72.05% |
| Definitive Healthcare | -72.28% | 3.55% | 1.63% |
Summary
Definitive Healthcare beats Firefly Neuroscience on 11 of the 14 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About Definitive Healthcare
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
